- Panel Appointed To Help Improve Lung Disease Services, UK
Patients with Chronic Obstructive Pulmonary Disease (COPD) will be offered more choice and improved standards of care thanks to a newly appointed panel advising on the development of a National Service Framework. - FDA Warns Three Pharmacies About Making Own Versions Of Brand-Name Drugs For Asthma
FDA in a press release Thursday said that it has warned three large pharmacies that they are in violation of federal law by producing and distributing unapproved "compounded" inhalation drugs, USA Today reports. Pharmacies are typically permitted to "compound," or formulate, drugs only when they have legitimate prescriptions for patients who need products not produced by commercial manufacturers. - Glade(R) Products Do Not Contain Ingredient Reported By The U.S. National Institutes Of Health
Today SC Johnson stated once again that none of its products contain the chemical ingredient 1,4 dichlorobenzene (1,4 DCB). This chemical has been the subject of a study done by the National Institute of Environmental Health Sciences (NIEHS). The study, published in the August 2006 issue of the journal Environmental Health Perspectives suggested exposure to 1,4 DCB (also known as paradichlorobenzene or pDCB) may cause modest reductions in lung function. - Why Colds Make Asthma Patients Have Severe Attacks?
We now know why catching the common cold makes it more probable that asthma patients have severe attacks, say researchers from Imperial College London and the Medical Research Council Centre in Allergic Mechanisms of Asthma. The findings could lead the way to prevent asthma attacks during a cold. You can read about this latest research in the journal Nature. - Medicines Regulator Informs Healthcare Professionals About Prescribing UK
The Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA) has written to healthcare professionals today about the prescribing of CFC-free inhalers to treat asthma. There are two CFC-free inhalers available on the UK market which contain the active substance beclometasone dipropionate, called Clenil Modulite and Qvar. - Monitoring Study Will Complement Previously Announced Clinical Development Program
Xenomics, Inc. (OTC Bulletin Board: XNOM; FWB:XE7), the source of next-generation medical DNA diagnostic technologies, today announced patient enrollment has begun at Italy's National Institute for Infectious Diseases "Lazzaro Spallanzani" for a tuberculosis monitoring study using Xenomics' proprietary Transrenal DNA (Tr-DNA) diagnostic technology - Airway Inflamation Caused By Trauma Of Chronic Cough
New findings suggest that airway trauma, caused by the act of coughing, may cause inflammation associated with chronic cough. Researchers from the University of Massachusetts Medical School conducted a cross-sectional, controlled study of 24 respiratory patients with chronic cough. The patients were split into four groups: intrapulmonary diseases, extrapulmonary diseases, unexplained cough, and four additional volunteers provided the nonsmoking, asymptomatic controls. - Hospitalization Varies Among Young Minorities With Asthma
A new, cross-sectional study reveals that health-care utilization of Puerto Rican and African-American children, residing in the same community, are disproportionate. Researchers from New England screened 6,554 children for asthma using a parental survey. Medicaid and Supplementary Children's Health Insurance Plan provided health-care utilization data that were collected for each child for the 12 preceding months. - Occupational Asthma Underdiagnosed By Clinicians
Clinicians may fail to recognize and effectively manage occupational asthma (OA) in newly diagnosed patients, according to a new study. Researchers from Duke and Stanford Universities analyzed the electronic medical records, pulmonary function test results, and questionnaire responses of 197 adults with newly diagnosed asthma at a California VA hospital. - Puerto Rican And African-American Children Show Different Patterns Of Asthma Care
Asthma has been on the rise for the past two decades, and minority populations have an especially high prevalence. A study in the August issue of the journal Chest suggests that Puerto Rican children with asthma make more clinic visits than African-American children with similar disease severity, but that the latter spend more time in the hospital for asthma. - Penn Researchers Use The Abdomen To Deliver Oxygen To Assist Ailing Lungs
Researchers at the University of Pennsylvania School of Medicine have helped develop a technique in animal models for using the abdominal cavity to exchange gas, supplementing the function normally performed by the lungs. The goal is to provide a way to support patients who are on a mechanical ventilator, suffering from reversible lung failure, but who need extra time and support to heal -- beyond what a ventilator can provide -- in order to survive. - Breathe Easier! Family Guide To Winter Allergies - Ten Tips On Improving Life In The Winter
Spring and summer are not the only seasons that bring misery to those with allergies. - Flu - A Shot In The Arm Could Save Your Child's Life
Flu season is approaching again, and parents should know that fall is the time to have your children immunized. This is especially important for children with asthma and other high-risk medical problems. - World Trade Center Dust Cuts Lung Function Capability In Rescue Workers
New York City firemen and emergency personnel exposed to dust from the collapse of the World Trade Center buildings experienced a decrease in lung function capability equal to 12 years of age-related decline during the year following the 9/11 disaster. - Astrazeneca Receives Japan Approval For CFC-free Corticosteroid Inhaler For Paediatric Asthma
Astrazeneca announced on July 27 that it had received approval for its Pulmicort Turbuhaler, an inhaler for pediatric asthma infants from 6 months to under 5 years old, frrom the Japanese Ministry of Health, Labor and Welfare. - Adams Respiratory Therapeutics Completes Repurchase Of Manufacturing Assets And Operations
Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) today announced that it has completed its previously announced repurchase of the manufacturing assets and operations in Fort Worth, Texas, from Cardinal Health. - MAP Pharmaceuticals Initiates Phase 2 Clinical Trial In Pediatric And Adolescent Patients
MAP Pharmaceuticals today announced the initiation and first patient dosing of a Phase 2 clinical trial evaluating MAP0010. MAP0010 is a proprietary nebulized formulation of budesonide for the inhalation treatment of asthma in both pediatric and adult populations. This novel approach to therapy is intended to provide the same efficacy as the currently marketed nebulizer product, but with a lower dose delivered in less time. - Mortality Rate Is Twice As High In Patients With Pneumonia Caused By Highly Resistant Bacteria
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria. A study published today in the journal Critical Care shows for the first time that the highly resistant, metallo-beta-lactamase-producing Pseudomonas aeruginosa is associated with a much higher mortality rate than other types of the bacteria in patients. - Critical Therapeutics Files Controlled Release Formulation Of Zileuton
SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) announces that its partner Critical Therapeutics Inc ("CTI", Nasdaq: CRTX) has submitted a New Drug Application to the US Food & Drug Administration for a controlled-release formulation of the oral anti- inflammatory drug zileuton for asthma in adults and children aged 12 years or older. The new formulation only needs to be taken twice a day whereas Zyflo(R), the currently marketed version of zileuton, has the drawback of requiring dosing four times a day. - JCI Publishes Preclinical Study Evaluating Potential Ability Of CVT-6883
CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that the Journal of Clinical Investigation (JCI) has published a preclinical study suggesting that CVT-6883 significantly reduced elevated markers of inflammation, fibrosis and pulmonary injury in two separate in vivo models. - Chemical In Many Air Fresheners May Reduce Lung Function
New research shows that a chemical compound found in many air fresheners, toilet bowl cleaners, mothballs and other deodorizing products, may be harmful to the lungs. Human population studies at the National Institute of Environmental Health Sciences (NIEHS), a part of the National Institutes of Health, found that exposure to a volatile organic compound (VOC), called 1,4 dichlorobenzene (1,4 DCB) may cause modest reductions in lung function. - Connexin Conducts Cell-to-cell Conversations In The Inflamed Lung
Severe lung inflammation, which can cause acute lung injury in cases of sepsis and infection, is associated with the accumulation in the lung and surrounding blood vessels of fluid, cells, and cellular debris. The deposition of inflammatory exudates spreads rapidly and can soon involve the entire lung or both lungs. The mechanisms underlying the spread of inflammation across the vast vascular network in the lung has remained unexplained, until now. - Giving The Right Number Of "\sighs" Prevents Ventilation Induced Lung Injury
Ventilation therapy burst into the public consciousness more than 60 years ago with the "iron lung" and the polio epidemic. Mechanical ventilation has come a long way since then and is used today with patients who cannot breathe on their own because of trauma, lung injuries and chronic lung disease. - Inhaled Nitric Oxide Reduces Lung Disease In Premature Babies
Delivering nitric oxide to the lungs of premature, very-low-birth-weight infants during their second week of life improves their chances of surviving without chronic lung disease, according to a national study of nearly 600 babies. For thousands of infants born prematurely each year in the United States, the treatment may help them to breathe easier - and shorten their hospital stay. - American Lung Association Collaborates With Leading Vaccine Manufacturer On New Initiative
The American Lung Association announced today it will collaborate on a new, far-reaching influenza public awareness initiative with sanofi pasteur, the nation's leading influenza vaccine manufacturer. As the nation's oldest voluntary health organization, the Lung Association will expand its annual influenza awareness efforts to educate the public about influenza and the need for vaccination through support and resources from sanofi pasteur.
|
